Fu-Quan Zhang Selected Research

Anthracyclines

1/2021	Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making.
1/2020	First-line non-anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG.
11/2019	Effect of primary tumor invasion on treatment and survival in extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: a multicenter study from the China Lymphoma Collaborative Group (CLCG).
12/2018	Risk-dependent curability of radiotherapy for elderly patients with early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fu-Quan Zhang Research Topics

Disease

10	Lymphoma (Lymphomas) 01/2021 - 09/2015
7	T-Cell Lymphoma (Lymphoma, T Cell) 01/2021 - 09/2015
6	Neoplasms (Cancer) 08/2022 - 01/2014
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 08/2012
2	Lung Neoplasms (Lung Cancer) 05/2024 - 01/2014
2	Extranodal NK-T-Cell Lymphoma 01/2021 - 10/2018
1	Adenocarcinoma of Lung 05/2024
1	Pathologic Constriction (Stenosis) 01/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018
1	Infections 01/2014
1	Rectal Neoplasms (Rectal Cancer) 03/2008

Drug/Important Bio-Agent (IBA)

4	AnthracyclinesIBA 01/2021 - 12/2018
2	4-iodobenzenesulfonamideIBA 01/2022 - 12/2019
1	Immune Checkpoint InhibitorsIBA 05/2024
1	Asparaginase (Elspar)FDA Link 10/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2015
1	Iodine-125IBA 05/2014
1	FITC-annexin A5IBA 01/2014
1	Messenger RNA (mRNA)IBA 01/2014
1	Caspase 3 (Caspase-3)IBA 01/2014
1	Caspase 8 (Caspase-8)IBA 01/2014
1	Proteins (Proteins, Gene)FDA Link 01/2014

Therapy/Procedure

13	Radiotherapy 08/2022 - 03/2008
8	Drug Therapy (Chemotherapy) 01/2021 - 03/2008
5	Therapeutics 05/2024 - 05/2014
2	Chemoradiotherapy 12/2019 - 03/2008
1	Immunotherapy 05/2024
1	Particle Accelerators 08/2022
1	Transplantation 01/2014
1	Neoadjuvant Therapy 03/2008